Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYCLOPHOSPHAMIDE FOR , USP for Acute leukaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 25 adverse event reports in the FDA FAERS database where CYCLOPHOSPHAMIDE FOR , USP was used for Acute leukaemia.

Most Reported Side Effects for CYCLOPHOSPHAMIDE FOR , USP

Side Effect Reports % Deaths Hosp.
Death 73 20.1% 73 1
Neoplasm progression 62 17.1% 62 0
Disease progression 39 10.7% 6 0
Neutropenia 32 8.8% 21 0
Thrombocytopenia 23 6.3% 22 0
Exposure during pregnancy 21 5.8% 0 0
Acute graft versus host disease 20 5.5% 0 0
Leukaemia recurrent 18 5.0% 18 0
Disease recurrence 16 4.4% 13 0
No adverse event 15 4.1% 0 0
Liver function test abnormal 7 1.9% 0 0
Precursor t-lymphoblastic lymphoma/leukaemia recurrent 6 1.7% 0 0
Bacteraemia 5 1.4% 0 0
Chronic graft versus host disease 5 1.4% 0 0
Dehydration 5 1.4% 0 4

Other Indications for CYCLOPHOSPHAMIDE FOR , USP

Breast cancer (98) Prophylaxis against graft versus host disease (25) Blast crisis in myelogenous leukaemia (21) Mantle cell lymphoma (21) Leukaemia (18) B-cell lymphoma (15) Plasma cell myeloma (14) Acute lymphocytic leukaemia (12) Diffuse large b-cell lymphoma (12) Myelodysplastic syndrome (12)

Other Drugs Used for Acute leukaemia

CYTARABINE (497) VENETOCLAX (407) METHOTREXATE (195) VINCRISTINE (164) AZACITIDINE (144) CYCLOPHOSPHAMIDE (124) DAUNORUBICIN (120) DEXAMETHASONE (110) DASATINIB (100) IDARUBICIN (85)

Related Pages

CYCLOPHOSPHAMIDE FOR , USP Full Profile All Acute leukaemia Drugs CYCLOPHOSPHAMIDE FOR , USP Demographics CYCLOPHOSPHAMIDE FOR , USP Timeline